Revitalist CEO Kathryn Walker On Ketamine, Psychedelic Investing, & The Future Of The Industry Oct 12, 2021
Numinus Offering Ketamine Assisted Psychotherapy At Two Clinics in Canada, Psychedelic Neurology Centre On The Horizon Oct 8, 2021
Mydecine Patent Filing Links Psychedelic Therapeutics & PTSD: Psychedelic Stock Investing Oct 7, 2021
Delic Labs Applies for Dealer’s License to Commercialize Psychedelics Research, Health Exemption to Test MDMA and… Oct 6, 2021
Awakn Life Sciences Announces Closing of Acquisition of Leading Ketamine-Assisted Psychotherapy Clinic in Norway Oct 5, 2021
Great News for Psychedelics Companies – Journey Clinical Raised $3M Funding For Mental Health Treatment Sep 30, 2021
MindMed Appoints University of North Carolina Psychiatrist and Pharmacologist Dr. Bryan Roth to Scientific Advisory… Sep 29, 2021
